The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded Dr. Neil Vasdev a grant to “support the development of tools to advance our understanding of Alzheimer’s disease by tracking its progression, improving patient selection for clinical trials, and monitoring patient response to drugs in trials.” Translation of an Optimized PET Radiopharmaceutical for Imaging Tau Pathology in […]
Tau proteins (named after the Greek letter T) are commonly associated with chronic neurodegenerative diseases such as Alzheimer’s disease (AD) and traumatic brain injuries. Positron Emission Tomography (PET), a non-invasive imaging technology, is used to measure disruptive tau accumulations in the brain. Currently there are few available PET tracers that can be used to measure […]